Matches in SemOpenAlex for { <https://semopenalex.org/work/W2768731567> ?p ?o ?g. }
- W2768731567 abstract "Type 2 diabetes mellitus (T2DM) is one of the most common diseases worldwide and insulin insufficiency and insulin resistance are two main metabolic issues connected with it. The dyslipidemia associated with insulin resistance and T2DM is characterized by higher triglycerides (TGs), higher very-low-density lipoprotein cholesterol and lower apo A1. Pioglitazone, a member of the thiazolidinedione class, with a proven antihyperglycemic effect, is known to positively influence insulin sensitivity and β-cell function and to have the potential to alter the lipid profile. The aim of our meta-analysis is to summarize and determine the influence of pioglitazone on the glycemic profile and lipoprotein metabolism as well as on weight and BMI in order to highlight the benefit of pioglitazone therapy in patients with T2DM. A comprehensive literature search was conducted through the electronic databases PubMed, MEDLINE, Scopus, PsyInfo, eLIBRARY.ru (from 2000 until February 2016) to identify studies that investigate the effect of pioglitazone on the glycemic and lipid profile and on the weight and BMI. We chose the random-effects method as the primary analysis. Forest plots depict estimated results from the studies included in the analysis and funnel plots are used to evaluate publication bias. Sensitivity analyses were performed in order to evaluate the degree of influence of the consequent elimination of each individual study on the final result. Of the 1536 identified sources only 15 randomised trials were included in the meta-analysis. Pioglitazone treatment was associated with improvement in the glycemic profile. It reduced FPG levels by a mean of 1.1–2 mmol/l and HbA1c by a mean of 0.9–1.3%. Our results reaffirmed the hypothesis that pioglitazone has a positive influence on the lipid profile of T2DM patients with increase in TC and HDL, no significant changes in LDL and notable decrease in TGs. Results also showed that pioglitazone therapy led to increase in both weight and BMI (WMD 1.755, 95% CI 0.674 to 2.837 and 1.145, 95% CI 0.389 to 1.901 respectively). Our results prove that the PPAR γ agonist pioglitazone has the potential to be beneficial to patients with T2DM." @default.
- W2768731567 created "2017-12-04" @default.
- W2768731567 creator A5020580988 @default.
- W2768731567 creator A5040681060 @default.
- W2768731567 creator A5061936161 @default.
- W2768731567 creator A5082882059 @default.
- W2768731567 date "2017-11-14" @default.
- W2768731567 modified "2023-10-09" @default.
- W2768731567 title "Effects of pioglitazone therapy on blood parameters, weight and BMI: a meta-analysis" @default.
- W2768731567 cites W1963886325 @default.
- W2768731567 cites W1966243777 @default.
- W2768731567 cites W1969377903 @default.
- W2768731567 cites W1984588810 @default.
- W2768731567 cites W1999169081 @default.
- W2768731567 cites W2000970191 @default.
- W2768731567 cites W2017030986 @default.
- W2768731567 cites W2023459427 @default.
- W2768731567 cites W2032716831 @default.
- W2768731567 cites W2034531911 @default.
- W2768731567 cites W2040493457 @default.
- W2768731567 cites W2046830335 @default.
- W2768731567 cites W2047591801 @default.
- W2768731567 cites W2063540564 @default.
- W2768731567 cites W2063641411 @default.
- W2768731567 cites W2067736115 @default.
- W2768731567 cites W2069665789 @default.
- W2768731567 cites W2072691447 @default.
- W2768731567 cites W2075227327 @default.
- W2768731567 cites W2089907280 @default.
- W2768731567 cites W2102675827 @default.
- W2768731567 cites W2103156933 @default.
- W2768731567 cites W2107298817 @default.
- W2768731567 cites W2107949845 @default.
- W2768731567 cites W2110641080 @default.
- W2768731567 cites W2112502827 @default.
- W2768731567 cites W2117852981 @default.
- W2768731567 cites W2124465362 @default.
- W2768731567 cites W2131330057 @default.
- W2768731567 cites W2138785582 @default.
- W2768731567 cites W2155161532 @default.
- W2768731567 cites W215860509 @default.
- W2768731567 cites W2160102993 @default.
- W2768731567 cites W2407846969 @default.
- W2768731567 cites W2423504141 @default.
- W2768731567 cites W2520433337 @default.
- W2768731567 cites W2619754961 @default.
- W2768731567 cites W2766317583 @default.
- W2768731567 cites W40400977 @default.
- W2768731567 cites W4235892613 @default.
- W2768731567 doi "https://doi.org/10.1186/s13098-017-0290-5" @default.
- W2768731567 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5686837" @default.
- W2768731567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29163673" @default.
- W2768731567 hasPublicationYear "2017" @default.
- W2768731567 type Work @default.
- W2768731567 sameAs 2768731567 @default.
- W2768731567 citedByCount "26" @default.
- W2768731567 countsByYear W27687315672018 @default.
- W2768731567 countsByYear W27687315672019 @default.
- W2768731567 countsByYear W27687315672020 @default.
- W2768731567 countsByYear W27687315672021 @default.
- W2768731567 countsByYear W27687315672022 @default.
- W2768731567 countsByYear W27687315672023 @default.
- W2768731567 crossrefType "journal-article" @default.
- W2768731567 hasAuthorship W2768731567A5020580988 @default.
- W2768731567 hasAuthorship W2768731567A5040681060 @default.
- W2768731567 hasAuthorship W2768731567A5061936161 @default.
- W2768731567 hasAuthorship W2768731567A5082882059 @default.
- W2768731567 hasBestOaLocation W27687315671 @default.
- W2768731567 hasConcept C126322002 @default.
- W2768731567 hasConcept C134018914 @default.
- W2768731567 hasConcept C2776923340 @default.
- W2768731567 hasConcept C2777180221 @default.
- W2768731567 hasConcept C2777391703 @default.
- W2768731567 hasConcept C2778096610 @default.
- W2768731567 hasConcept C2778270857 @default.
- W2768731567 hasConcept C2778384471 @default.
- W2768731567 hasConcept C2779306644 @default.
- W2768731567 hasConcept C2780473172 @default.
- W2768731567 hasConcept C2910068830 @default.
- W2768731567 hasConcept C511355011 @default.
- W2768731567 hasConcept C555293320 @default.
- W2768731567 hasConcept C71924100 @default.
- W2768731567 hasConcept C95190672 @default.
- W2768731567 hasConceptScore W2768731567C126322002 @default.
- W2768731567 hasConceptScore W2768731567C134018914 @default.
- W2768731567 hasConceptScore W2768731567C2776923340 @default.
- W2768731567 hasConceptScore W2768731567C2777180221 @default.
- W2768731567 hasConceptScore W2768731567C2777391703 @default.
- W2768731567 hasConceptScore W2768731567C2778096610 @default.
- W2768731567 hasConceptScore W2768731567C2778270857 @default.
- W2768731567 hasConceptScore W2768731567C2778384471 @default.
- W2768731567 hasConceptScore W2768731567C2779306644 @default.
- W2768731567 hasConceptScore W2768731567C2780473172 @default.
- W2768731567 hasConceptScore W2768731567C2910068830 @default.
- W2768731567 hasConceptScore W2768731567C511355011 @default.
- W2768731567 hasConceptScore W2768731567C555293320 @default.
- W2768731567 hasConceptScore W2768731567C71924100 @default.
- W2768731567 hasConceptScore W2768731567C95190672 @default.
- W2768731567 hasIssue "1" @default.
- W2768731567 hasLocation W27687315671 @default.